2A Pharma

2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP platform.

Our Mission

To develop novel, cost effective prophylactic and therapeutic vaccines based on the AAVLP platform for the benefit of both future vaccine recipients and our investors.

LEARN MORE

Recent news

2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP Platform.

The International Day of Women and Girls in Science is dedicated to empowering women and achieving equal access and participation in science.

...

READ MORE

2A Pharma celebrates its 5th anniversary

On December 12, 2021, it has been five years since 2A Pharma was founded.
This is a good time to look back and be proud of what we’ve accomplished. Watch the video to see the highlights of the past 5 years.

READ MORE

Jeanette presents E-poster at IPVC 2021

The virtual 34th International Papillomavirus Conference took place last week, from November 15-19. The conference’s theme this year was: ‘Research and education for HPV elimination’.

...

READ MORE